Core Viewpoint - The company, Giant Bio (02367.HK), has been actively repurchasing its shares, indicating a potential confidence in its stock value and a strategy to enhance shareholder value through buybacks [1] Group 1: Share Buyback Details - On December 22, the company repurchased 400,000 shares at a price range of HKD 35.860 to HKD 36.340, totaling HKD 14.4297 million [1] - The stock closed at HKD 36.060 on the same day, reflecting a 1.63% increase, with a total trading volume of HKD 192 million [1] - Since December 9, the company has conducted buybacks for 10 consecutive days, accumulating a total of 4 million shares repurchased at a total cost of HKD 141 million [1] Group 2: Historical Buyback Data - The buyback details for the past days are as follows: - December 19: 40,000 shares at a maximum price of HKD 35.520 and a total cost of HKD 14.0536 million [1] - December 18: 40,000 shares at a maximum price of HKD 35.040 and a total cost of HKD 13.8830 million [1] - December 17: 40,000 shares at a maximum price of HKD 35.220 and a total cost of HKD 13.9713 million [1] - December 16: 40,000 shares at a maximum price of HKD 35.400 and a total cost of HKD 14.0261 million [1] - December 15: 40,000 shares at a maximum price of HKD 35.240 and a total cost of HKD 13.9173 million [1] - December 12: 40,000 shares at a maximum price of HKD 35.220 and a total cost of HKD 14.0364 million [1] - December 11: 40,000 shares at a maximum price of HKD 35.360 and a total cost of HKD 13.8876 million [1] - December 10: 40,000 shares at a maximum price of HKD 36.220 and a total cost of HKD 14.3824 million [1] - December 9: 40,000 shares at a maximum price of HKD 36.180 and a total cost of HKD 14.3764 million [1]
巨子生物(02367.HK)12月22日回购40.00万股，耗资1442.97万港元